Birchview Capital »

Stoke Therapeutics shares owned by Birchview Capital

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Birchview Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.8M 210k 13.51
2024-03-31 $2.8M 210k 13.50
2023-12-31 $1.1M 210k 5.26
2023-09-30 $335k 85k 3.94
2023-06-30 $904k 85k 10.63
2023-03-31 $125k 15k 8.33
2022-12-31 $138k 15k 9.20
2022-09-30 $193k 15k 12.87
2022-06-30 $198k 15k 13.20
2022-03-31 $316k 15k 21.07
2021-12-31 $360k 15k 24.00
2021-09-30 $382k 15k 25.47
2021-06-30 $505k 15k 33.67
2021-03-31 $583k 15k 38.87
2020-12-31 $1.2M 20k 61.95
2020-09-30 $670k 20k 33.50
2020-06-30 $477k 20k 23.85
2020-03-31 $458k 20k 22.90